Skip to main content

Conduction Defect

0
Pipeline Programs
1
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AtaCor Medical
AtaCor MedicalCA - San Clemente
3 programs
AtaCor StealthTrac LeadN/A4 trials
StealthTrac Temporary Pacing LeadN/A1 trial
Subcostal Temporary Extracardiac Pacing LeadN/A1 trial
Active Trials
NCT05610033Completed12Est. Jan 2024
NCT05633394Completed29Est. Jun 2025
NCT05457673Completed12Est. Oct 2022
+3 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AtaCor MedicalAtaCor StealthTrac Lead
AtaCor MedicalAtaCor StealthTrac Lead
AtaCor MedicalAtaCor StealthTrac Lead
AtaCor MedicalAtaCor StealthTrac Lead
AtaCor MedicalStealthTrac Temporary Pacing Lead
AtaCor MedicalSubcostal Temporary Extracardiac Pacing Lead

Clinical Trials (6)

Total enrollment: 105 patients across 6 trials

NCT05610033AtaCor MedicalAtaCor StealthTrac Lead

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

Start: Sep 2023Est. completion: Jan 202412 patients
N/ACompleted
NCT05633394AtaCor MedicalAtaCor StealthTrac Lead

Subcostal Temporary Extravascular Pacing V Study

Start: Jan 2023Est. completion: Jun 202529 patients
N/ACompleted
NCT05457673AtaCor MedicalAtaCor StealthTrac Lead

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study

Start: Aug 2022Est. completion: Oct 202212 patients
N/ACompleted
NCT04538287AtaCor MedicalAtaCor StealthTrac Lead

AtaCor Subcostal Temporary Extravascular Pacing III Study

Start: Oct 2020Est. completion: May 202233 patients
N/ACompleted
NCT04374929AtaCor MedicalStealthTrac Temporary Pacing Lead

Subcostal Temporary Extracardiac Pacing II Study

Start: Jul 2020Est. completion: May 20217 patients
N/ACompleted
NCT04096365AtaCor MedicalSubcostal Temporary Extracardiac Pacing Lead

Subcostal Temporary Extracardiac Pacing Study

Start: Aug 2019Est. completion: Nov 201912 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.